双鹭药业,002038,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1534,131,1403,91.45%,3.09% 生物、生化药,28773,3834,24938,86.67%,54.87% 其他,3215,2010,1206,37.5%,2.65% 化学药,20194,2295,17899,88.64%,39.38% 双鹭药业,002038,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化学药,54101,5604,48498,89.64%,30.08% 其他,664,597,67,10.08%,0.04% 其他(补充),2113,1740,374,17.68%,0.23% 生物、生化药,146092,33797,112294,76.87%,69.65% 双鹭药业,002038,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化学药,20910,2035,18875,90.27%,22.24% 生物、生化药,83703,17968,65735,78.53%,77.44% 其他,107,90,17,15.46%,0.02% 其他(补充),308,47,261,84.75%,0.31% 双鹭药业,002038,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,33,42,-9,-25.87%,-0.01% 化学药,37060,3743,33317,89.9%,19.38% 其他(补充),2416,1160,1256,51.99%,0.73% 生物、生化药,177238,39883,137355,77.5%,79.89% 双鹭药业,002038,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化学药,17054,1612,15442,90.55%,18.68% 生物、生化药,80124,13510,66615,83.14%,80.6% 其他,13,16,-4,-29.86%,-0% 其他(补充),882,290,592,67.11%,0.72% 双鹭药业,002038,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1889,466,1424,75.35%,1.62% 其他,22,43,-20,-91.16%,-0.02% 化学药,17073,3084,13989,81.93%,15.94% 生物、生化药,105223,32838,72385,68.79%,82.46% 双鹭药业,002038,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),157,172,-14,-9.09%,-0.04% 其他,7,24,-17,-257.25%,-0.05% 化学药,6631,2113,4518,68.13%,13.66% 生物、生化药,39816,11235,28581,71.78%,86.43% 双鹭药业,002038,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1837,532,1305,71.02%,1.98% 其他,961,317,644,67.06%,0.98% 化学药,12851,4513,8338,64.88%,12.66% 生物、生化药,85336,29764,55572,65.12%,84.38% 双鹭药业,002038,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2069,249,1820,87.96%,5.27% 其他,159,97,62,38.89%,0.18% 化学药,5011,2533,2477,49.44%,7.18% 生物、生化药,39997,9838,30159,75.4%,87.37% 双鹭药业,002038,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),-- ,128,-- ,--,0% 其他,5268,573,4695,89.12%,6.14% 化学药,12757,4568,8190,64.2%,10.72% 生物、生化药,97629,34090,63539,65.08%,83.14% 双鹭药业,002038,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1513,328,1185,78.31%,3.02% 化学药,7455,3646,3810,51.1%,9.73% 其他(补充),1783,250,1533,86%,3.91% 生物、生化药,43123,10479,32645,75.7%,83.34% 双鹭药业,002038,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3600,282,3318,92.17%,3.81% 生物、生化药,101278,32573,68705,67.84%,78.92% 其他,3575,647,2928,81.89%,3.36% 化学药,15842,3740,12102,76.39%,13.9% 双鹭药业,002038,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),676,296,380,56.26%,0.88% 其他,1542,188,1353,87.78%,3.14% 化学药,9177,4463,4714,51.37%,10.95% 生物、生化药,47293,10701,36592,77.37%,85.02% 双鹭药业,002038,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1423,540,883,62.05%,1.13% 其他,3500,528,2972,84.91%,3.79% 化学药,13153,3398,9756,74.17%,12.46% 生物、生化药,98102,33397,64706,65.96%,82.62% 双鹭药业,002038,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1975,271,1704,86.3%,4.62% 化学药,9531,4785,4746,49.8%,12.87% 生物、生化药,42930,12511,30419,70.86%,82.5% 双鹭药业,002038,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,5518,1719,3799,68.85%,5.61% 化学药,12894,3350,9543,74.02%,14.1% 生物、生化药,82290,27961,54329,66.02%,80.28% 双鹭药业,002038,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1176,310,867,73.66%,3.02% 化学药等,6181,1399,4781,77.36%,16.66% 生物、生化药,31772,9532,22240,70%,77.48% 技术转让、服务,958,143,815,85.08%,2.84% 双鹭药业,002038,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,892,107,785,88.02%,1.67% 销售药品,59097,14850,44247,74.87%,94.21% 其他(补充),2288,354,1934,84.52%,4.12% 双鹭药业,002038,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,414,55,359,86.73%,1.76% 销售药品,26317,6268,20049,76.18%,98.24% 双鹭药业,002038,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,575,135,440,76.59%,1.29% 销售药品,44097,10280,33817,76.69%,98.71% 双鹭药业,002038,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 技术服务费,151,53,98,65.05%,0.57% 销售商品,21042,3785,17257,82.01%,99.43% 双鹭药业,002038,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 技术服务费,131,21,109,83.69%,0.36% 销售商品,36024,6197,29826,82.8%,99.64% 双鹭药业,002038,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 销售商品,15318,2376,12942,84.49%,100% 双鹭药业,002038,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 技术转让、服务,2479,433,2047,82.55%,6.62% 销售商品,33321,4471,28850,86.58%,93.38% 双鹭药业,002038,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 技术转让,1301,83,1218,93.64%,8.93% 销售商品,14599,2173,12426,85.12%,91.07% 双鹭药业,002038,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 立生素,2371,194,2177,91.82%,22.14% 欣吉尔,2398,225,2173,90.6%,22.09% 贝科能,9933,4447,5486,55.23%,55.77% 双鹭药业,002038,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化药,6692,3359,3333,49.81%,57.47% 生物药,2691,224,2467,91.69%,42.53% 双鹭药业,002038,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化药,9220,4816,4404,47.77%,48.5% 生物药,5174,497,4677,90.39%,51.5% 双鹭药业,002038,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化药,1933,890,1043,53.96%,44.73% 生物药,1407,118,1289,91.6%,55.27% 双鹭药业,002038,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化、化学药,4290,2441,1849,43.1%,45.25% 生物药,2503,266,2237,89.38%,54.75% 双鹭药业,002038,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化药,1577,843,734,46.56%,41.31% 生物药,1188,145,1043,87.81%,58.69% 双鹭药业,002038,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化药,7037,4000,3037,43.16%,41.8% 生物药,4819,591,4228,87.74%,58.2% 双鹭药业,002038,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化药,1705,918,787,46.14%,38.3% 生物药,1428,160,1267,88.78%,61.7% 双鹭药业,002038,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 生化、化学药,3191,1908,1283,40.21%,41.54% 生物药,2083,277,1805,86.68%,58.46%